The role of interstitial stress in lymphatic function and lymphangiogenesis

Annals of the New York Academy of Sciences

Volumn 979, Issue , 2002, Pages 197-210

  Swartz, Melody A ^a   Boardman Jr , Kendrick C ^a  

^a Northwestern University   (United States)

Author keywords

Growth factors; Interstitial stress; Lymphangiogenesis; Lymphatic function

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FLOW KINETICS; FLUID BALANCE; FLUID FLOW; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; REGULATORY MECHANISM; SHEAR RATE; SHEAR STRESS;

ANIMALIA;

EID: 0036962345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04880.x     Document Type: Conference Paper

References (33)

1. AUKLAND, K. & R.K. REED. 1993. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol. Rev. 73: 1-78.
2. SCHMID-SCHÖNBEIN, G.W. 1990. Microlymphatics and lymph flow. Physiol. Rev. 70: 987-1028.
3. LEAK, L.V. & J.F. BURKE. 1966. Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am. J. Anat. 118: 785-810.
4. LEAK, L.V. & J.F. BURKE. 1968. Ultrastructural studies on the lymphatic anchoring filaments. J. Cell Biol. 36: 129-149.
5. IKOMI, F. & G.W. SCHMID-SCHÖNBEIN. 1996. Lymph pump mechanics in the rabbit hind leg. Am. J. Physiol. 271: H173-83.
6. SCHMID-SCHÖNBEIN, G.W. 1990. Mechanisms causing initial lymphatics to expand and compress to promote lymph flow. Arch. Histol. Cytol. 53 Suppl.: 107-114.
7. GRANGER, H.J. 1981. Physicochemical properties of the extracellular matrix. In Tissue Fluid Pressure and Composition. A.R. Hargens, Ed.: 43-61. Williams & Wilkins. Baltimore, MD.
8. GRODZINSKY, A.J. 1983. Electromechanical and physicochemical properties of connective tissue. Crit. Rev. Biomed. Eng. 9: 133-199.
9. HARGENS, A.R., Ed. 1981. Tissue Fluid Pressure and Composition. Williams & Wilkins. Baltimore, MD.
10. LEVICK, J. 1987. Flow through interstitium and other fibrous matrices. Quart. Rev. Exp. Physiol. 72: 409-438.
11. KENEDI, R.M., T. GIBSON & C.H. DALY. 1965. Bio-engineering studies of the human skin. In Biomechanics and Related Bio-Engineering Topics. R.M. Kenedi, Ed.: 147-158. Pergamon Press. Oxford.
12. MARKENSCOFF, X. & I.V. YANNAS. 1979. On the stress-strain relation for skin. J. Biomech. 12: 127-129.
13. SWARTZ, M.A. et al. 1999. Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J. Biomech. 32: 1297-1301.
14. BUDGE, A. 1880. Über lymphherzen bei hühnerembryonen. Arch. Anat. Entwickl.-Gesch.: 350-359.
15. SALA, L. 1900. Sullo sviluppo dei cuori linfatici e dei dotti torici nell' embryone di pollo. Ric. Lab. Anat. Norm. Univ. Roma. 7: 899-1000.
16. OHTA, Y., V. SHRIDHAR, R.K. BRIGHT, et al. 1999. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br. J. Cancer. 81: 54-61.
17. KARPANEN, T. 2001. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61: 1786-1790.
18. MANDRIOTA, S.J. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO 20: 672-682.
19. SKOBE, M., et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 7: 192-198.
20. PEPPER, M.S. 2001. Lymphangiogenesis and tumor metastasis: myth or reality? Clin. Cancer Res. 7: 462-468.
21. JOUKOV, V. et al. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15: 1751.
22. LEE, J., et al. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt-4. Proc. Natl. Acad. Sci. USA. 93: 1988-1992.
23. JELTSCH, M. et al. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
24. OH, S.J., et al. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188: 96-109.
25. JOUKOV, V. et al. 1997. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16: 3898-3911.
26. ACHEN, M.G., et al. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. 95: 548-53.
27. STACKER, S.A., et al. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Med. 7: 186-191.
28. BERK, D.A. et al. 1996. Transport in lymphatic capillaries: II. Microscopic velocity measurement with fluorescence recovery after photobleaching. Am. J. Physiol. 270: H330-7.
29. SWARTZ, M.A., D.A. BERK & R.K. JAIN. 1996. Transport in lymphatic capillaries: I. Macroscopic measurment using residence time distribution analysis. Am. J. Physiol. 270: H324-329.
30. BOARDMAN, K.C. & M.A. SWARTZ. Interstitial flow as a guide for lymphangiogenesis. Submitted for publication.
31. CARREIRA, C.M. et al. 2001. LYVE-1 is not restricted to lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61: 8079-8084.
32. VALTOLA, R. et al. 1999. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154: 1381-1390.
33. PARTANEN, T.A. et al. 2000. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 14: 2087-2096.